Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 312

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial

Open access
Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.-S., Aliot, E., Boursier, M., Bizeau, O., Kacet, S., for the ECOST trial Investigators · 2013 · European Heart Journal

Abstract

AIMS: The ECOST trial examined prospectively the long-term safety and effectiveness of home monitoring (HM) of implantable cardioverter defibrillators (ICD). METHODS AND RESULTS: The trial's primary objective was to randomly compare the proportions of patients experiencing ≥ 1 major adverse event (MAE), including deaths from all causes, and cardiovascular, procedure-related, and device-related MAE associated with HM (active group) vs. ambulatory follow-ups (control group) in a sample of 433 patients. The 221 patients assigned to the active group were seen once a year, unless HM reported an ICD dysfunction or a clinical event requiring an ambulatory visit, while the 212 patients in the control group underwent ambulatory visits every 6 months. The characteristics of the study groups were similar. Over a follow-up of 24.2 months, 38.5% of patients in the active and 41.5% in the control group experienced ≥ 1 MAE (P < 0.05 for non-inferiority). The overall number of shocks delivered was significantly lower in the active (n = 193) than in the control (n = 657) group (P < 0.05) and the proportion of patients who received inappropriate shocks was 52% lower in the active (n = 11) than in the control (n = 22) group (P < 0.05). At the end of the follow-up, the battery longevity was longer in the active group because of a lower number of capacitor charges (499 vs. 2081). CONCLUSION: Our observations indicate that long-term HM of ICD is at least as safe as standard ambulatory follow-ups with respect to a broad spectrum of MAE. It also lowered significantly the number of appropriate and inappropriate shocks delivered, and spared the device battery. Clinical trials registration NCT00989417.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehs425

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 312

Metadata

Authors
Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.-S., Aliot, E., Boursier, M., Bizeau, O., Kacet, S., & for the ECOST trial Investigators
Venue
European Heart Journal
Published
2012-12-13
Volume
34
Issue
8
Pages
605-614
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2131839079
Cited by
312
References
23
FWCI
13.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehs425
The paper
Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.-S., Aliot, E., Boursier, M., Bizeau, O., Kacet, S., & for the ECOST trial Investigators. (2013). A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehs425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.